LSKL

Grade: Research grade

Factory Location: Hangzhou

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe, Australasia,Asia,Middle East,Africa

Monthly Production Capacity: hundreds of grams

Packaging Information: 500mg,1g, 10g,50g 100g per package with icebag

Delivery Lead Time: In stock or 2-3weeks

Sample Provided: yes

Payment Terms: T/T

LSKL is an inhibitor peptide composed of 4 amino acids. It is a peptide derived from a latency-related peptide, which can inhibit the activation of TGF-β thrombospondin (TSP-1) and prevent liver damage and fibrosis; at the same time, LSKL It can easily cross the blood-brain barrier and reduce hydrocephalus; LSKL can successfully reduce the activation of TGF-β-Smad signal by antagonizing TSP-1, but cannot reduce the protein expression of TSP-1; LSKL can also promote liver after hepatectomy Cell Proliferation.